查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1838445

2034 年生物製药市场分析与预测：类型、产品、服务、技术、应用、最终用户、流程、设备、材料类型和部署

Biologics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Device, Material Type, Deployment
出版日期: | 出版商: Global Insight Services | 英文 393 Pages | 商品交期: 3-5个工作天内

价格
简介目录

生物製药市场预计将从 2024 年的 5.815 亿美元增至 2034 年的 13.232 亿美元，复合年增长率约为 8.6%。生物製药市场包括源自生物来源，例如蛋白质、核酸和细胞。这些生物製药对于治疗癌症和自体免疫疾病等慢性疾病至关重要。生物技术的进步、慢性病的增加以及对个人化医疗日益增长的需求正在推动市场的发展。单株抗体、基因疗法和生物相似药的创新正在扩大治疗选择并提高疗效。监管支持和战略合作伙伴关係正在进一步推动市场成长，使生物製药成为现代治疗方法的基石。

在生物技术和个人化医疗进步的推动下，生物製药市场正在强劲扩张。单株抗体市场因其在治疗慢性病和癌症方面的有效性而成为领先的细分市场。重组蛋白紧随其后，反映出它们在治疗和疫苗中的应用日益广泛。在基因工程和标靶治疗技术进步的推动下，基因治疗显示出巨大的潜力。随着干细胞研究取得了有希望的治疗成果，细胞治疗正在获得发展动能。由于需要品牌生物製剂的经济高效的替代品，生物相似药的重要性日益增加。这一趋势正在推动人们转向更易于获得的医疗保健解决方案。市场对先进药物输送系统的需求也激增，这些系统可以提高生物製药治疗的疗效和患者依从性。生物製药公司之间的策略联盟与合作正在促进创新并加速新型生物製剂的市场开发，为市场持续成长和丰厚利润奠定基础。

市场区隔
类型 单株抗体、疫苗、重组蛋白、基因治疗、细胞治疗、生物相似药、血液製品、酶
产品 治疗性蛋白质、抗体药物复合体、细胞激素、融合蛋白、生长因子、荷尔蒙、干扰素、白细胞介素
服务 合约研究、契约製造、临床试验、监管服务、品质保证、供应链管理、物流
科技 DNA定序、CRISPR、合成生物学、生物加工、奈米技术、蛋白质工程、生物列印
目的 肿瘤科、感染疾病、自体免疫疾病、心血管疾病、代谢性疾病、神经内科、眼科、皮肤科
最终用户 製药公司、生技公司、研究机构、医院、诊所、诊断实验室、学术机构
过程 上游工程、下​​游加工、配方、纯化、发酵、细胞培养
装置 生物反应器、离心机、层析法系统、过滤系统、混合系统
材料类型 蛋白质、抗体、核酸、细胞、病毒载体
部署 内部、外包、混合

市场概述

生物製药继续主导製药行业，透过创新和成熟的治疗方法占据了相当大的市场份额。定价策略根据生产的复杂性和临床疗效而有所不同。新产品频繁推出，反映了生物技术的进步以及单株治疗方法、疫苗和基因疗法的强大研发管线。对个人化医疗和标靶治疗日益增长的需求正在推动市场发展。北美和欧洲是领先地区，而亚太地区由于医疗保健投资的增加和政府的支持政策而正在经历加速成长。生物製药市场竞争激烈，主要企业在大力投资研发以维持竞争优势。监管起着至关重要的作用，严格的核准流程影响市场进入和扩张。 FDA 和 EMA 设定了高标准以确保安全性和有效性，这可能会延迟产品上市，但最终会增强市场信心。新兴市场提供了有利可图的机会，但驾驭不同的监管环境需要策略敏锐性。生物製药的未来充满希望，细胞和基因治疗的进步推动着创新和市场发展。

主要趋势和驱动因素：

在生物技术进步和个人化医疗需求日益增长的推动下，生物製药市场正经历强劲成长。主要趋势包括单株抗体、细胞和基因疗法的兴起，它们正在彻底改变各种疾病的治疗模式。这些技术创新源自于对疾病机制和人类基因组的更深入理解。监管支援和快速核准途径正在进一步加速市场扩张。世界各国政府都认识到生物製药在满足未满足医疗需求方面的潜力，并正在简化核准流程。此外，慢性病的流行和人口老化是主要驱动因素，因此需要新的治疗方案。生物製药产业也大力投资研发。各公司正专注于扩大产能和改善药物输送系统。在医疗基础设施不断发展的新兴市场中，机会无限。策略联盟和伙伴关係日益盛行，使各公司得以利用互补优势，扩大全球影响力。在持续创新和策略倡议的推动下，生物製药市场可望持续成长。

限制与挑战：

生物製药市场目前面临若干重大限制与挑战。其中一个主要挑战是生物製药价格高昂，这限制了患者获得药物的机会，并给医疗保健系统带来了经济负担。生物製药的复杂製造过程需要在专业设施和技术人员方面进行大量投资，这进一步加剧了这个问题。此外，监管障碍也带来了巨大的挑战。严格的生物製剂核准程序导致时间过长和成本增加，阻碍了中小企业进入市场。智慧财产权问题也构成了重大障碍。专利到期为生物相似药打开了大门，加剧了竞争并影响了市场份额。供应链中断通常由地缘政治紧张局势或全球健康危机引发，可能导致生物製剂短缺和分销延迟。最后，对低温运输物流的需求进一步增加了复杂性和成本，阻碍了市场扩张，尤其是在资源匮乏的环境中。

主要企业

山德士、三星生物製剂、Biocon、康泰伦特、药明生物製剂、龙沙、赛多利斯、勃林格殷格翰、富士迪奥辛斯生物技术、艾布泽纳、AGC生物製剂、三星Bioepis、思拓凡、巴伐利亚北欧、MorphoSys

目录

第一章生物製药市场概述

  • 调查目的
  • 生物製药市场定义与研究范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章：生物製药市场展望

  • 生物製药市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章生物製药市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章：生物製药市场规模

  • 生物製药市场规模（以价值计算）
  • 生物製药市场规模（按数量）

第七章生物製药市场（按类型）

  • 市场概况
  • 单株抗体
  • 疫苗
  • 重组蛋白
  • 基因治疗
  • 细胞疗法
  • 生物相似药
  • 血液製品
  • 酵素
  • 其他的

第八章生物製药市场（按产品）

  • 市场概况
  • 治疗性蛋白质
  • 抗体药物复合体
  • 细胞激素
  • 融合蛋白
  • 生长因子
  • 荷尔蒙
  • 干扰素
  • 白细胞介素
  • 其他的

第九章生物製药市场（按服务）

  • 市场概况
  • 合约研究
  • 契约製造
  • 临床试验
  • 医药服务
  • 品质保证
  • 供应链管理
  • 物流
  • 其他的

第 10 章 生物製药市场（按技术）

  • 市场概况
  • DNA定序
  • CRISPR
  • 合成生物学
  • 生物过程
  • 奈米科技
  • 蛋白质工程
  • 生物列印
  • 其他的

第11章生物製药市场（依应用）

  • 市场概况
  • 肿瘤学
  • 感染疾病
  • 自体免疫疾病
  • 心血管疾病
  • 代谢紊乱
  • 神经病学
  • 眼科
  • 皮肤科
  • 其他的

第 12 章生物製药市场（依最终用户）

  • 市场概况
  • 製药公司
  • 生技公司
  • 研究所
  • 医院
  • 诊所
  • 诊断实验室
  • 学术机构
  • 其他的

第十三章生物製药市场（按製程）

  • 市场概况
  • 上游工程
  • 下游工艺
  • 配方
  • 纯化
  • 发酵
  • 细胞培养
  • 其他的

第十四章生物製药市场（按设备）

  • 市场概况
  • 生物反应器
  • 离心机
  • 层析法系统
  • 过滤系统
  • 混合系统
  • 其他的

第 15 章。按材料类型分類的生物製药市场

  • 市场概况
  • 蛋白质
  • 抗体
  • 核酸
  • 细胞
  • 病毒载体
  • 其他的

第十六章生物製药市场（按部署）

  • 市场概况
  • 内部
  • 外包
  • 杂交种
  • 其他的

第十七章生物製药市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十八章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十九章：公司简介

  • Sandoz
  • Samsung Biologics
  • Biocon
  • Catalent
  • WuXi Biologics
  • Lonza
  • Sartorius
  • Boehringer Ingelheim
  • Fujifilm Diosynth Biotechnologies
  • Abzena
  • AGC Biologics
  • Samsung Bioepis
  • Cytiva
  • Bavarian Nordic
  • MorphoSys
简介目录
Product Code: GIS33678

Biologics Market is anticipated to expand from $581.5 million in 2024 to $1,323.2 million by 2034, growing at a CAGR of approximately 8.6%. The Biologics Market encompasses therapeutic products derived from living organisms, including proteins, nucleic acids, and cells. These biologics are pivotal in treating chronic diseases such as cancer and autoimmune disorders. The market is driven by advancements in biotechnology, increasing prevalence of chronic diseases, and rising demand for personalized medicine. Innovations in monoclonal antibodies, gene therapies, and biosimilars are expanding treatment options and enhancing efficacy. Regulatory support and strategic collaborations further propel market growth, positioning biologics as a cornerstone of modern therapeutics.

The Biologics Market is experiencing robust expansion, driven by advancements in biotechnology and personalized medicine. The monoclonal antibodies segment emerges as the top-performing sub-segment, owing to their efficacy in treating chronic diseases and cancer. Recombinant proteins follow closely, reflecting increased applications in therapeutic treatments and vaccines. Gene therapy showcases significant potential, propelled by innovations in genetic engineering and targeted treatments. The cell therapy sub-segment is gaining momentum, with stem cell research offering promising therapeutic outcomes. Biosimilars are becoming increasingly relevant, driven by the need for cost-effective alternatives to branded biologics. This trend is prompting a shift towards more accessible healthcare solutions. The market is also witnessing a surge in demand for advanced drug delivery systems, enhancing the efficacy and patient compliance of biologic treatments. Strategic partnerships and collaborations between biopharmaceutical companies are fostering innovation and accelerating the development of novel biologics, positioning the market for sustained growth and lucrative opportunities.

Market Segmentation
TypeMonoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy, Cell Therapy, Biosimilars, Blood Products, Enzymes
ProductTherapeutic Proteins, Antibody Drug Conjugates, Cytokines, Fusion Proteins, Growth Factors, Hormones, Interferons, Interleukins
ServicesContract Research, Contract Manufacturing, Clinical Trials, Regulatory Services, Quality Assurance, Supply Chain Management, Logistics
TechnologyDNA Sequencing, CRISPR, Synthetic Biology, Bioprocessing, Nanotechnology, Protein Engineering, Bioprinting
ApplicationOncology, Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Disorders, Neurology, Ophthalmology, Dermatology
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Hospitals, Clinics, Diagnostic Labs, Academic Institutions
ProcessUpstream Processing, Downstream Processing, Formulation, Purification, Fermentation, Cell Culture
DeviceBioreactors, Centrifuges, Chromatography Systems, Filtration Systems, Mixing Systems
Material TypeProteins, Antibodies, Nucleic Acids, Cells, Viral Vectors
DeploymentIn-house, Outsourced, Hybrid

Market Snapshot:

Biologics continue to dominate the pharmaceutical landscape, with significant market share held by innovative therapies and established treatments. Pricing strategies vary, driven by the complexity of production and clinical efficacy. New product launches are frequent, reflecting advancements in biotechnology and a robust pipeline of monoclonal antibodies, vaccines, and gene therapies. The market is buoyed by increasing demand for personalized medicine and targeted therapies. North America and Europe are key regions, though Asia-Pacific is witnessing accelerated growth due to rising healthcare investments and supportive government policies. Competition in the biologics market is intense, with leading companies investing heavily in R&D to maintain their competitive edge. Regulatory influences play a pivotal role, with stringent approval processes impacting market entry and expansion. The FDA and EMA set high standards, ensuring safety and efficacy, which can delay product launches but ultimately enhance market credibility. Emerging markets offer lucrative opportunities, yet navigating diverse regulatory landscapes requires strategic acumen. Biologics' future is promising, with advancements in cell and gene therapies driving innovation and market evolution.

Geographical Overview:

The biologics market is witnessing robust growth across diverse regions, each presenting unique opportunities. North America retains a dominant position, bolstered by advanced healthcare infrastructure and significant R&D investments. The presence of leading biopharmaceutical firms further drives innovation and market expansion. Europe follows, with its strong emphasis on biotechnology research and favorable regulatory frameworks enhancing market dynamics. The Asia Pacific region is experiencing rapid market growth, driven by an increasing prevalence of chronic diseases and rising healthcare expenditure. Countries like China and India are emerging as lucrative markets due to their large patient populations and government support for biotechnology. Latin America presents promising growth prospects, with Brazil and Mexico investing in healthcare advancements. The Middle East & Africa region is gradually gaining traction, with countries like the UAE and South Africa recognizing the potential of biologics in improving healthcare outcomes. These emerging markets offer significant opportunities for expansion and investment in the biologics sector.

Key Trends and Drivers:

The biologics market is experiencing robust growth, fueled by advancements in biotechnology and increased demand for personalized medicine. Key trends include the rise of monoclonal antibodies and cell and gene therapies, which are revolutionizing treatment paradigms across various diseases. These innovations are driven by a deeper understanding of disease mechanisms and the human genome. Regulatory support and expedited approval pathways are further accelerating market expansion. Governments are recognizing the potential of biologics to address unmet medical needs, thus streamlining approval processes. Additionally, the increasing prevalence of chronic diseases and aging populations are significant drivers, necessitating novel therapeutic solutions. The biopharmaceutical industry is also witnessing substantial investments in research and development. Companies are focusing on enhancing production capabilities and improving drug delivery systems. Opportunities abound in emerging markets, where healthcare infrastructure is evolving. Strategic collaborations and partnerships are becoming prevalent, enabling firms to leverage complementary strengths and expand their global footprint. The biologics market is poised for sustained growth, driven by continuous innovation and strategic initiatives.

Restraints and Challenges:

The biologics market is currently encountering several significant restraints and challenges. One of the primary challenges is the high cost of biologic drugs, which limits accessibility for patients and places a financial burden on healthcare systems. The complexity of manufacturing processes for biologics further exacerbates this issue, as it requires significant investment in specialized facilities and skilled personnel. Additionally, regulatory hurdles present another formidable challenge. The stringent approval processes for biologics can lead to prolonged timelines and increased costs, discouraging smaller companies from entering the market. Intellectual property concerns also pose a significant barrier, as patent expirations open the door to biosimilars, intensifying competition and impacting market share. Supply chain disruptions, often caused by geopolitical tensions or global health crises, can lead to shortages and delays in the distribution of biologics. Lastly, the need for cold chain logistics adds another layer of complexity and cost, hindering market expansion, particularly in low-resource settings.

Key Players:

Sandoz, Samsung Biologics, Biocon, Catalent, WuXi Biologics, Lonza, Sartorius, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, Abzena, AGC Biologics, Samsung Bioepis, Cytiva, Bavarian Nordic, MorphoSys

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biologics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Biologics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by Material Type
  • 2.12 Key Highlights of the Market, by Deployment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by Material Type
  • 3.11 Market Attractiveness Analysis, by Deployment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Biologics Market Outlook

  • 4.1 Biologics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Biologics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Biologics Market Size

  • 6.1 Biologics Market Size, by Value
  • 6.2 Biologics Market Size, by Volume

7: Biologics Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Recombinant Proteins
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Gene Therapy
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Biosimilars
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Blood Products
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Enzymes
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Biologics Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Proteins
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Antibody Drug Conjugates
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cytokines
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Fusion Proteins
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Growth Factors
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Hormones
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Interferons
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Interleukins
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Biologics Market, by Services

  • 9.1 Market Overview
  • 9.2 Contract Research
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Contract Manufacturing
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Clinical Trials
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Regulatory Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Quality Assurance
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Supply Chain Management
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Logistics
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Biologics Market, by Technology

  • 10.1 Market Overview
  • 10.2 DNA Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 CRISPR
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Synthetic Biology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Bioprocessing
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Nanotechnology
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Protein Engineering
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Bioprinting
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Others
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region

11: Biologics Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Infectious Diseases
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Autoimmune Diseases
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Cardiovascular Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Metabolic Disorders
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Neurology
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Ophthalmology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Dermatology
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region
  • 11.10 Others
    • 11.10.1 Key Market Trends & Opportunity Analysis
    • 11.10.2 Market Size and Forecast, by Region

12: Biologics Market, by End User

  • 12.1 Market Overview
  • 12.2 Pharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Biotechnology Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Hospitals
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Clinics
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Diagnostic Labs
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region
  • 12.8 Academic Institutions
    • 12.8.1 Key Market Trends & Opportunity Analysis
    • 12.8.2 Market Size and Forecast, by Region
  • 12.9 Others
    • 12.9.1 Key Market Trends & Opportunity Analysis
    • 12.9.2 Market Size and Forecast, by Region

13: Biologics Market, by Process

  • 13.1 Market Overview
  • 13.2 Upstream Processing
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Downstream Processing
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Formulation
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Purification
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Fermentation
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Cell Culture
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region
  • 13.8 Others
    • 13.8.1 Key Market Trends & Opportunity Analysis
    • 13.8.2 Market Size and Forecast, by Region

14: Biologics Market, by Device

  • 14.1 Market Overview
  • 14.2 Bioreactors
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Centrifuges
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Chromatography Systems
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Filtration Systems
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Mixing Systems
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Biologics Market, by Material Type

  • 15.1 Market Overview
  • 15.2 Proteins
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Antibodies
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Nucleic Acids
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Cells
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Viral Vectors
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region
  • 15.7 Others
    • 15.7.1 Key Market Trends & Opportunity Analysis
    • 15.7.2 Market Size and Forecast, by Region

16: Biologics Market, by Deployment

  • 16.1 Market Overview
  • 16.2 In-house
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Outsourced
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Hybrid
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Biologics Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Process
    • 17.2.9 North America Market Size and Forecast, by Device
    • 17.2.10 North America Market Size and Forecast, by Material Type
    • 17.2.11 North America Market Size and Forecast, by Deployment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Process
      • 17.2.9.8 United States Market Size and Forecast, by Device
      • 17.2.9.9 United States Market Size and Forecast, by Material Type
      • 17.2.9.10 United States Market Size and Forecast, by Deployment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Process
      • 17.2.10.8 Canada Market Size and Forecast, by Device
      • 17.2.10.9 Canada Market Size and Forecast, by Material Type
      • 17.2.10.10 Canada Market Size and Forecast, by Deployment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Process
    • 17.3.9 Europe Market Size and Forecast, by Device
    • 17.3.10 Europe Market Size and Forecast, by Material Type
    • 17.3.11 Europe Market Size and Forecast, by Deployment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Process
      • 17.3.10.8 Germany Market Size and Forecast, by Device
      • 17.3.10.9 Germany Market Size and Forecast, by Material Type
      • 17.3.10.10 Germany Market Size and Forecast, by Deployment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Process
      • 17.3.11.8 France Market Size and Forecast, by Device
      • 17.3.11.9 France Market Size and Forecast, by Material Type
      • 17.3.11.10 France Market Size and Forecast, by Deployment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Process
      • 17.3.12.8 Spain Market Size and Forecast, by Device
      • 17.3.12.9 Spain Market Size and Forecast, by Material Type
      • 17.3.12.10 Spain Market Size and Forecast, by Deployment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Process
      • 17.3.13.8 Italy Market Size and Forecast, by Device
      • 17.3.13.9 Italy Market Size and Forecast, by Material Type
      • 17.3.13.10 Italy Market Size and Forecast, by Deployment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Process
      • 17.3.14.8 Netherlands Market Size and Forecast, by Device
      • 17.3.14.9 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.10 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Process
      • 17.3.15.8 Sweden Market Size and Forecast, by Device
      • 17.3.15.9 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.10 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Process
      • 17.3.16.8 Switzerland Market Size and Forecast, by Device
      • 17.3.16.9 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.10 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Process
      • 17.3.17.8 Denmark Market Size and Forecast, by Device
      • 17.3.17.9 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.10 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Process
      • 17.3.18.8 Finland Market Size and Forecast, by Device
      • 17.3.18.9 Finland Market Size and Forecast, by Material Type
      • 17.3.18.10 Finland Market Size and Forecast, by Deployment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Process
      • 17.3.19.8 Russia Market Size and Forecast, by Device
      • 17.3.19.9 Russia Market Size and Forecast, by Material Type
      • 17.3.19.10 Russia Market Size and Forecast, by Deployment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Process
      • 17.4.9.8 China Market Size and Forecast, by Device
      • 17.4.9.9 China Market Size and Forecast, by Material Type
      • 17.4.9.10 China Market Size and Forecast, by Deployment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Process
      • 17.4.10.8 India Market Size and Forecast, by Device
      • 17.4.10.9 India Market Size and Forecast, by Material Type
      • 17.4.10.10 India Market Size and Forecast, by Deployment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Process
      • 17.4.11.8 Japan Market Size and Forecast, by Device
      • 17.4.11.9 Japan Market Size and Forecast, by Material Type
      • 17.4.11.10 Japan Market Size and Forecast, by Deployment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Process
      • 17.4.12.8 South Korea Market Size and Forecast, by Device
      • 17.4.12.9 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.10 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Process
      • 17.4.13.8 Australia Market Size and Forecast, by Device
      • 17.4.13.9 Australia Market Size and Forecast, by Material Type
      • 17.4.13.10 Australia Market Size and Forecast, by Deployment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Process
      • 17.4.14.8 Singapore Market Size and Forecast, by Device
      • 17.4.14.9 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.10 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Process
      • 17.4.15.8 Indonesia Market Size and Forecast, by Device
      • 17.4.15.9 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.10 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Process
      • 17.4.16.8 Taiwan Market Size and Forecast, by Device
      • 17.4.16.9 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.10 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Process
      • 17.4.17.8 Malaysia Market Size and Forecast, by Device
      • 17.4.17.9 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.10 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Process
    • 17.5.9 Latin America Market Size and Forecast, by Device
    • 17.5.10 Latin America Market Size and Forecast, by Material Type
    • 17.5.11 Latin America Market Size and Forecast, by Deployment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Process
      • 17.5.9.8 Brazil Market Size and Forecast, by Device
      • 17.5.9.9 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.10 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Process
      • 17.5.10.8 Mexico Market Size and Forecast, by Device
      • 17.5.10.9 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.10 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Process
      • 17.5.11.8 Argentina Market Size and Forecast, by Device
      • 17.5.11.9 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.10 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Process
      • 17.6.10.8 UAE Market Size and Forecast, by Device
      • 17.6.10.9 UAE Market Size and Forecast, by Material Type
      • 17.6.10.10 UAE Market Size and Forecast, by Deployment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Process
      • 17.6.11.8 South Africa Market Size and Forecast, by Device
      • 17.6.11.9 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.10 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Sandoz
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Samsung Biologics
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Biocon
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Catalent
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 WuXi Biologics
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Lonza
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sartorius
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Boehringer Ingelheim
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Fujifilm Diosynth Biotechnologies
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Abzena
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 AGC Biologics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Samsung Bioepis
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Cytiva
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Bavarian Nordic
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 MorphoSys
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis